Click for best price
NextGeneration Immunology Drugs Market Size, Share 2024
The global Next-Generation Immunology Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Cell Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Next-Generation Immunology Drugs include Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company and Merck & Co., Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Immunology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Immunology Drugs. This report contains market size and forecasts of Next-Generation Immunology Drugs in global, including the following market information:
Global Next-Generation Immunology Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Next-Generation Immunology Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next-Generation Immunology Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Next-Generation Immunology Drugs Market Segment Percentages, by Type, 2023 (%)
Cell Therapy
Small Molecule Drug
Others
Global Next-Generation Immunology Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Next-Generation Immunology Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Next-Generation Immunology Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Next-Generation Immunology Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next-Generation Immunology Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Next-Generation Immunology Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc
Abbvie Inc.
Johnson and Johnson
F. Hoffmann-La Roche Ltd.
Amgen Inc.
Novartis AG
Astellas Pharma Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc.
Eli Lilly and Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next-Generation Immunology Drugs, market overview.
Chapter 2: Global Next-Generation Immunology Drugs market size in revenue.
Chapter 3: Detailed analysis of Next-Generation Immunology Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next-Generation Immunology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Next-Generation Immunology Drugs Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Next-Generation Immunology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next-Generation Immunology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next-Generation Immunology Drugs Overall Market Size
2.1 Global Next-Generation Immunology Drugs Market Size: 2023 VS 2030
2.2 Global Next-Generation Immunology Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next-Generation Immunology Drugs Players in Global Market
3.2 Top Global Next-Generation Immunology Drugs Companies Ranked by Revenue
3.3 Global Next-Generation Immunology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Next-Generation Immunology Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Next-Generation Immunology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next-Generation Immunology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Next-Generation Immunology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Next-Generation Immunology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next-Generation Immunology Drugs Market Size Markets, 2023 & 2030
4.1.2 Cell Therapy
4.1.3 Small Molecule Drug
4.1.4 Others
4.2 By Type - Global Next-Generation Immunology Drugs Revenue & Forecasts
4.2.1 By Type - Global Next-Generation Immunology Drugs Revenue, 2019-2024
4.2.2 By Type - Global Next-Generation Immunology Drugs Revenue, 2025-2030
4.2.3 By Type - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next-Generation Immunology Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Next-Generation Immunology Drugs Revenue & Forecasts
5.2.1 By Application - Global Next-Generation Immunology Drugs Revenue, 2019-2024
5.2.2 By Application - Global Next-Generation Immunology Drugs Revenue, 2025-2030
5.2.3 By Application - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Next-Generation Immunology Drugs Market Size, 2023 & 2030
6.2 By Region - Global Next-Generation Immunology Drugs Revenue & Forecasts
6.2.1 By Region - Global Next-Generation Immunology Drugs Revenue, 2019-2024
6.2.2 By Region - Global Next-Generation Immunology Drugs Revenue, 2025-2030
6.2.3 By Region - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Next-Generation Immunology Drugs Revenue, 2019-2030
6.3.2 US Next-Generation Immunology Drugs Market Size, 2019-2030
6.3.3 Canada Next-Generation Immunology Drugs Market Size, 2019-2030
6.3.4 Mexico Next-Generation Immunology Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Next-Generation Immunology Drugs Revenue, 2019-2030
6.4.2 Germany Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.3 France Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.4 U.K. Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.5 Italy Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.6 Russia Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Next-Generation Immunology Drugs Market Size, 2019-2030
6.4.8 Benelux Next-Generation Immunology Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Next-Generation Immunology Drugs Revenue, 2019-2030
6.5.2 China Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.3 Japan Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.4 South Korea Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Next-Generation Immunology Drugs Market Size, 2019-2030
6.5.6 India Next-Generation Immunology Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Next-Generation Immunology Drugs Revenue, 2019-2030
6.6.2 Brazil Next-Generation Immunology Drugs Market Size, 2019-2030
6.6.3 Argentina Next-Generation Immunology Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next-Generation Immunology Drugs Revenue, 2019-2030
6.7.2 Turkey Next-Generation Immunology Drugs Market Size, 2019-2030
6.7.3 Israel Next-Generation Immunology Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Next-Generation Immunology Drugs Market Size, 2019-2030
6.7.5 UAE Next-Generation Immunology Drugs Market Size, 2019-2030
7 Next-Generation Immunology Drugs Companies Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Next-Generation Immunology Drugs Major Product Offerings
7.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 Abbvie Inc.
7.2.1 Abbvie Inc. Company Summary
7.2.2 Abbvie Inc. Business Overview
7.2.3 Abbvie Inc. Next-Generation Immunology Drugs Major Product Offerings
7.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.2.5 Abbvie Inc. Key News & Latest Developments
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Company Summary
7.3.2 Johnson and Johnson Business Overview
7.3.3 Johnson and Johnson Next-Generation Immunology Drugs Major Product Offerings
7.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.3.5 Johnson and Johnson Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Company Summary
7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.4.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.5 Amgen Inc.
7.5.1 Amgen Inc. Company Summary
7.5.2 Amgen Inc. Business Overview
7.5.3 Amgen Inc. Next-Generation Immunology Drugs Major Product Offerings
7.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.5.5 Amgen Inc. Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Next-Generation Immunology Drugs Major Product Offerings
7.6.4 Novartis AG Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Company Summary
7.7.2 Astellas Pharma Inc. Business Overview
7.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Major Product Offerings
7.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.7.5 Astellas Pharma Inc. Key News & Latest Developments
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Company Summary
7.8.2 Bristol-Myers Squibb Company Business Overview
7.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.8.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Company Summary
7.9.2 Merck & Co., Inc. Business Overview
7.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Major Product Offerings
7.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.9.5 Merck & Co., Inc. Key News & Latest Developments
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Company Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Major Product Offerings
7.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue in Global Market (2019-2024)
7.10.5 Eli Lilly and Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Next-Generation Immunology Drugs Market Opportunities & Trends in Global Market
Table 2. Next-Generation Immunology Drugs Market Drivers in Global Market
Table 3. Next-Generation Immunology Drugs Market Restraints in Global Market
Table 4. Key Players of Next-Generation Immunology Drugs in Global Market
Table 5. Top Next-Generation Immunology Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Next-Generation Immunology Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Next-Generation Immunology Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Next-Generation Immunology Drugs Product Type
Table 9. List of Global Tier 1 Next-Generation Immunology Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next-Generation Immunology Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Next-Generation Immunology Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Next-Generation Immunology Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Next-Generation Immunology Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Next-Generation Immunology Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Next-Generation Immunology Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Next-Generation Immunology Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Next-Generation Immunology Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Next-Generation Immunology Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Next-Generation Immunology Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Next-Generation Immunology Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Next-Generation Immunology Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Next-Generation Immunology Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Next-Generation Immunology Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Next-Generation Immunology Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Pfizer Inc Company Summary
Table 31. Pfizer Inc Next-Generation Immunology Drugs Product Offerings
Table 32. Pfizer Inc Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Pfizer Inc Key News & Latest Developments
Table 34. Abbvie Inc. Company Summary
Table 35. Abbvie Inc. Next-Generation Immunology Drugs Product Offerings
Table 36. Abbvie Inc. Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Abbvie Inc. Key News & Latest Developments
Table 38. Johnson and Johnson Company Summary
Table 39. Johnson and Johnson Next-Generation Immunology Drugs Product Offerings
Table 40. Johnson and Johnson Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Johnson and Johnson Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Ltd. Company Summary
Table 43. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product Offerings
Table 44. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 46. Amgen Inc. Company Summary
Table 47. Amgen Inc. Next-Generation Immunology Drugs Product Offerings
Table 48. Amgen Inc. Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Amgen Inc. Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Next-Generation Immunology Drugs Product Offerings
Table 52. Novartis AG Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Novartis AG Key News & Latest Developments
Table 54. Astellas Pharma Inc. Company Summary
Table 55. Astellas Pharma Inc. Next-Generation Immunology Drugs Product Offerings
Table 56. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Astellas Pharma Inc. Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Company Summary
Table 59. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product Offerings
Table 60. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Bristol-Myers Squibb Company Key News & Latest Developments
Table 62. Merck & Co., Inc. Company Summary
Table 63. Merck & Co., Inc. Next-Generation Immunology Drugs Product Offerings
Table 64. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Merck & Co., Inc. Key News & Latest Developments
Table 66. Eli Lilly and Company Company Summary
Table 67. Eli Lilly and Company Next-Generation Immunology Drugs Product Offerings
Table 68. Eli Lilly and Company Next-Generation Immunology Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Eli Lilly and Company Key News & Latest Developments
List of Figures
Figure 1. Next-Generation Immunology Drugs Segment by Type in 2023
Figure 2. Next-Generation Immunology Drugs Segment by Application in 2023
Figure 3. Global Next-Generation Immunology Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Next-Generation Immunology Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Next-Generation Immunology Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Next-Generation Immunology Drugs Revenue in 2023
Figure 8. By Type - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Next-Generation Immunology Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Next-Generation Immunology Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 16. US Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 28. China Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Next-Generation Immunology Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Next-Generation Immunology Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Pfizer Inc Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abbvie Inc. Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Johnson and Johnson Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Amgen Inc. Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novartis AG Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Eli Lilly and Company Next-Generation Immunology Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
